Summary The cytotoxic mechanism of a conjugate of doxorubicin (DXR) and glutathione (GSH) via glutaraldehyde (GSH-DXR) was investigated using DXR-sensitive (AH66P) and -resistant (AH66DR) rat hepatoma cells. GSH-DXR accumulated in AH66DR cells as well as in AH66P cells without efflux by P-gp and exhibited the potent cytocidal activity against both cells compared with DXR. To examine whether thiol from GSH-DXR affected the expression of cytotoxicity, two conjugates of DXR, with modified peptides containing alanine or serine substituted for cysteine in GSH were prepared and their cytotoxicities determined. Substitution of these amino acids for cysteine resulted in an approximately two-to fourfold reduction in cytotoxic activity against both cell lines compared with the effect of GSH-DXR. Depletion of intracellular GSH by treatment of both cells with buthionine sulphoximine did not change the cytotoxic activity of DXR, BSA-DXR or GSH-DXR. By co-treating the cells with tributyltin acetate, an inhibitor of glutathione S-transferase (GST), and either DXR, BSA-DXR or GSH-DXR, the cytotoxicity was markedly increased. Interestingly, GSH-DXR showed non-competitive inhibition of GST activity and its IC 50value was 1.3 ,UM. These results suggested that the inhibition of GST activity by GSH-DXR must be an important contribution to the expression of potent cytotoxicity of the drug.
Several mechanisms, either alone or in combination, have been proposed to explain cellular drug resistance. They are: overproduction of multidrug resistance (MDR)-related 170-kDa P-glycoprotein (P-gp) (Riordan et al, 1985; Endicott and Ling 1989) ; increase in the glutathione (GSH) content (Hamilton, et al, 1985; Russo and Mitchell, 1985) ; enhanced expression of glutathione S-transferase (GST) (Batist et al, 1986; Black et al, 1988 ; Lewis et al, 1988; Tew 1994) ; and change in topoisomerase II activity (Beck, 1989; Isabella et al, 1991) in the resistant cells.
It has been reported that drug resistance is reversed by a variety of substances, such as an inhibitor of the P-gp efflux pump and anti-P-gp antibody for MDR (Tsuruo et al, 1982; FitzGerald et al, 1987; Twentyman et al, 1987; Tsuruo et al, 1989; Chen et al, 1991) , and an inhibitor of GST or of GSH synthase in the GSH/GST detoxification system (Tew et al, 1988; Petrini et al, 1993 ; Lee et al, 1996) . We have reported that a conjugate of DXR with bovine serum albumin (BSA) (BSA-DXR) reversed MDR and markedly increased cytotoxicity against several MDR cell lines (Hatano et al, 1993; Ohkawa et al, 1993a,b) ; we have also reported that the liberation of the degraded active adducts with a molecular weight of approximately 2 kDa of BSA-DXR by lysosomal breakdown was essential for the expression of cytotoxicity (Takahashi et al, 1996) . Moreover, a recent study revealed that DXR conjugated to GSH (GSH-DXR) with rapid intracellular accumulation without efflux improved the cytotoxicity against MDR cells (Asakura et al, 1997) . As the GSH-DXR exhibited potent cytotoxicity against not only MDR-cells but also DXRsensitive cells, the effect of GSH-DXR on GST activity was examined using DXR-sensitive and -resistant rat hepatoma cells.
MATERIALS AND METHODS Materials
DXR was obtained from Kyowa Hakko Kogyo (Tokyo, Japan).
BSA, GSH, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazorium bromide (MTT), verapamil, 1-chloro-2,4-dinitrobenzene (CDNB), tributyltin acetate, D,L-buthionine-S,R-sulphoximine (BSO) and o-phthalaldehyde were obtained from Sigma Chemical (St Louis, MO, USA). Dowex 50Wx8, glycylglycylglycine (triGly) and glutaraldehyde were purchased from Nakarai Tesque (Kyoto, Japan). y-Glutamylalanylglycine (EAG) and y-glutamylserylglycine (ESG) were obtained from Sawaday Technology (Tokyo, Japan). All other chemicals were of analytical grade.
Cell lines
The rat ascites hepatoma cell line AH66P and DXR-resistant mutant subline AH66DR (10 gIM DXR resistance), were cultured with RPMI-1640 medium containing 10% heat-inactivated fetal bovine serum (growth medium) under conventional conditions (Ohkawa et al, 1993a,b; Takahashi et al, 1996; Asakura et al, 1997) . (Hatano et al, 1993; Ohkawa et al, 1993a,b) . All drugs were filter-sterilized by a 0.45-,um syringe filter (Coming Coster, Tokyo, Japan). The concentration of DXR was measured by absorbance at 495 nm.
Cytotoxicity of DXR conjugates
To assess the growth-inhibitory effect of the conjugates, viable AH66P and AH66DR cells (2 x 104) were cultured continuously for 96 h in a 48-well culture plate (Coming Coster) with 0.5 ml of growth medium containing graded equivalent concentrations of DXR in the presence or absence of 5 giM verapamil (an inhibitor of the P-gp efflux pump), 4 ,UM BSO (an inhibitor of GSH synthase) or 0.3 gM tributyltin acetate (an inhibitor of GST). After incubation, viable cells were determined with the colorimetric assay using MTT as described previously (Mosmann, 1983) , and the results were expressed by the following equation: survival rate (%) = 100 x (absorbance at 570 nm of the drug-exposed cells)/ (absorbance at 570 nm of the non-treated control cells).
Intracellular accumulation of drugs
After 24 Table 1 . -X-, DXR; -A-, BSA-DXR; -A-, triGly-DXR; -0-, GSH-DXR; -0-, EAG-DXR; -E-; ESG-DXR three times, then sonicated mildly in 10 mm Tris-HCl (pH 7.4). The intracellular DXR was measured by fluorospectrometry as described previously (Asakura et al, 1997) .
Measurement of cellular GSH concentration
After incubation with BSO or GSH-DXR, the collected cells were suspended in 10 mm sodium phosphate buffer (pH 7.4). The cell suspension was mixed with 0.1 M perchloric acid and the mixture (0.2 ml) was centrifuged at 10000 g for 10 min. The resultant supematant was neutralized with sodium hydroxide and incubated with 2 ml of 0.1 M sodium phosphate buffer (pH 8.2) containing 50 tl of 1% o-phthalaldehyde in methanol at room temperature for 30 min. After incubation, the mixture was measured by fluorospectrometry at an emission wavelength of 420 nm with an excitation wavelength of 350 nm (Jocelyn et al, 1970) .
Assay of GST activity
The scraped and washed cells were sonicated in 10 mm sodium phosphate buffer (pH 7.4) and the resultant suspension was used as the enzymatic source. GST activity was measured at 340 nm (£ = 9600) in 1 mm CDNB, 1 mm GSH and 0.1 M sodium phosphate buffer (pH 6.5) at 37°C for 10 min in the presence or absence of test drugs (Habig et al, 1974 ).
British Journal of Cancer (1997) Protein determination The protein concentration was assayed by a Bio-Rad protein assay kit using BSA as the standard.
RESULTS

Cytotoxicity and accumulation of drugs in the cells
As shown in Figure 1 , GSH-DXR exhibited potent cytotoxicity to both AH66P and AH66DR cells compared with DXR, triGly-DXR or BSA-DXR. In AH66DR cells, BSA-DXR and GSH-DXR accumulated without efflux by P-gp and the addition of 5 ,UM verapamil caused only a slight increase in the intracellular accumulation of both conjugates (Table 1) . In contrast, the intracellular accumulation of DXR and triGly-DXR was low and treatment of the cells with verapamil markedly increased the intracellular accumulation of these drugs.
Reduction of cytotoxic activity by removal of thiol from GSH-DXR
The intracellular accumulation of EAG-DXR or ESG-DXR reached the same concentration as that of GSH-DXR in both AH66P and AH66DR cells (Table 1) . Unexpectedly, the cytotoxicity of EAG-DXR or ESG-DXR was obviously reduced two-or (Figure 2 ).
The IC 5 value of tributyltin acetate for GST activity was 3 gM (data not shown).
Inhibitory effect of conjugates on GST activity
Incubating the cell extracts from either AH66P or DR cells with the conjugates, GSH-DXR and EAG-DXR inhibited the enzyme activity of GST (Figure 3) . IC50 values of GSH-DXR and EAG-DXR for the enzyme activity were 1.3 and 10 gM respectively, in the extract from AH66P cells and 1.2 and 11 JIM respectively in the extract from AH66DR cells. GSH-DXR acted as a noncompetitive inhibitor to the enzyme, GST in both cell lines ( Figure  3, insert) . DXR, triGly-DXR, BSA-DXR and ESG-DXR showed no significant inhibition of the GST activity up to 10 gM of equivalent concentrations of DXR. DISCUSSION GSH-DXR exhibited a superior cytotoxic efficacy against both DXR-sensitive and -resistant cells relative to DXR. Our recent report demonstrated that GSH-DXR accumulated in MDR cells with minimal efflux by P-gp and the accumulation of GSH-DXR in both AH66P and AH66DR cells showed the same uptake pattern as that of DXR in AH66P cells (Asakura et al, 1997) . It was suggested that the conjugates GSH-DXR, EAG-DXR and ESG-DXR were not recognized by the P-gp efflux pump because of their strong acidity compared with DXR or triGly-DXR. This result supports the notion that P-gp extrudes hydrophobic and mostly cationic compounds from cancer cells at physiological pH (Gottesman and Pastan, 1993) .
Although GSH-DXR accumulated in AH66P cells at a lower concentration than did DXR, GSH-DXR showed 170-fold more cytotoxic activity than DXR. The conjugates with the substitution of amino acids for cysteine, EAG-DXR and ESG-DXR, demonstrated a significant reduction in the cytotoxic efficacy in tumour cells relative to GSH-DXR without any significant difference in intracellular drug concentration between GSH-DXR and EAG-or ESG-DXR. This result indicates that the thiol group of GSH-DXR plays an important role in the expression of increased cytotoxicity. An approximately 80% reduced cellular GSH content was probably not sufficient to suppress GSH/GST-mediated drug detoxification because the reduced GSH concentration was still almost equal to that in normal rat liver (4.95 nmol mg-' protein of wholetissue homogenate) measured in our experiment.
The activity of GST in cell extracts prepared from either AH66P or AH66DR cells was inhibited markedly by the addition of GSH-DXR or EAG-DXR, and their IC50 values for the GST activity were 1.3 gM and 10 gM respectively in the extract from AH66P cells and 1.2 gM and 11 JIM respectively in the extract from AH66DR cells. It has been reported that some compounds in which the alkyl group was coupled to the thiol of GSH inhibited GST activity (Lyttle et al, 1994) . Although GSH-DXR in the present study consisted of DXR conjugated to the amino group of GSH and not to thiol, the conjugate showed the potent inhibition of the GST activity. In contrast to this result, the addition of GSH-DXR, at the concentration to exhibit almost the same cytotoxicities, to cultured AH66P and AH66DR cells did not induce any significant decrease in GST activity compared with that in cells cultured without GSH-DXR. The discrepancy between these two results might be derived from the fact that the GSH-DXR concentration in the cells was diluted 2500-fold with GST assay medium and consequently GST activity was not inhibited by such a low concentration of GSH-DXR when GST activity was measured in the extracts from GSH-DXR-treated cells. As about 14% of the added GSH-DXR was accumulated in AH66DR cells during the 24-h incubation period, the intracellular drug concentration was estimated to be 1.4 gM (1.4 mmol kg-' wet weight of the cells) by the addition of 0.2 nmol GSH-DXR to 2 ml of the culture media containing 20 mg wet weight of AH66DR cells. Under these conditions, the treatment of AH66DR cells with 100 nM (0.2 nmol 2 ml-') GSH-DXR was sufficient to inhibit the intracellular (in situ) GST activity (approximately 50% inhibition). Similarly, by treating AH66P cells with 10 nM GSH-DXR, the intracellular concentration of GSH-DXR was estimated to be 0.15 ,UM. This concentration of GSH-DXR was equivalent to 20% inhibitory concentration of GST activity. Moreover, the cytotoxic efficacy of DXR, BSA-DXR or GSH-DXR was further increased approximately two-to ninefold relative to the control when the cells were cotreated with both drugs and tributyltin acetate, an inhibitor of GST. The degree of enhancement of the cytotoxic activity of GSH-DXR was, however, smaller than that of DXR or BSA-DXR after treatment with tributyltin acetate. This result might explain why the inhibition of GST activity induced by GSH-DXR treatment had already increased the cytotoxicity before the addition of tributyltin acetate, suggesting that the cytotoxic effect of these drugs was partly suppressed by the action of GST. EAG-DXR also showed moderate, but significant inhibition of the enzyme activity. In contrast, ESG-DXR did not exhibit any inhibitory effect on GST activity, but the cytotoxicity of ESG-DXR was 60-fold higher than that of DXR against AH66P cells.
